Related Experiment Video
Updated: Mar 9, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
miR-340 Inhibits Proliferation and Induces Apoptosis in Gastric Cancer Cell Line SGC-7901, Possibly via the AKT
Jinzhong Yu1, Ruijie Wang2, Jianshe Chen3
1Department of Gastroenterology, Henan Province Hospital of TCM, Zhengzhou, Henan, China (mainland).
Abstract:
BACKGROUND Gastric cancer is among the most common types of cancer, with high morbidity and mortality. MicroRNAs (miRNAs) play vital roles in the tumorigenesis and biology of gastric cancer. This study aimed to reveal the role of miR-340 in gastric cancer cell proliferation and apoptosis and to elucidate the potential mechanisms. MATERIAL AND METHODS Human gastric cancer cells SGC-7901 were used in this study for cell transfection with miR-340 mimic or inhibitor. After transfection, cell viability, proliferation, and apoptosis were examined by MTT, BrdU, and flow cytometry assays, respectively. The protein level changes of p27, p21, Caspase 3 (CASP3), B cell lymphoma 2 (BCL2), BCL2-associated X protein (BAX), and v-AKT murine thymoma viral oncogene (AKT) were detected by Western blot. RESULTS Overexpression of miR-340 significantly reduced cell viability and proliferation (P<0.01), and induced cell apoptosis (P<0.01) of SGC-7901. miR-340 elevated the protein level of cell cycle inhibitor p27, but did not affect the level of p21. Apoptosis-related factors pro-CASP3, cleaved-CASP3, and BAX were promoted, and BCL2 was inhibited by miR-340. miR-340 also suppressed the phosphorylation of AKT. Opposite effects were detected when SGC-7901 cells were transfected with miR-340 inhibitor. CONCLUSIONS These results indicate that miR-340 can inhibit proliferation and induce apoptosis of SGC-7901 cells, suggesting its roles in protecting against gastric cancer. The roles of miR-340 in gastric cancer cells may be associated with its regulation of the AKT pathway. Thus, miR-340 may be a potential therapeutic strategy for gastric cancer treatment.
Insights
MicroRNA 340 (miR-340) inhibits gastric cancer cell growth and promotes apoptosis. This microRNA may serve as a potential therapeutic target for gastric cancer treatment by regulating the AKT pathway.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Gastric cancer is a leading cause of cancer-related deaths globally.
- MicroRNAs (miRNAs) are critical regulators in cancer development and progression.
- Understanding specific miRNA roles, like miR-340, is crucial for gastric cancer research.
Purpose of the Study:
- To investigate the function of miR-340 in gastric cancer cell proliferation and apoptosis.
- To elucidate the underlying molecular mechanisms, including pathway involvement.
Main Methods:
- Human gastric cancer cells (SGC-7901) were transfected with miR-340 mimic or inhibitor.
- Cell viability, proliferation, and apoptosis were assessed using MTT, BrdU, and flow cytometry.
- Protein expression of key apoptosis and cell cycle regulators (p27, p21, CASP3, BCL2, BAX, AKT) was analyzed via Western blot.
Main Results:
- Overexpression of miR-340 significantly decreased SGC-7901 cell viability and proliferation.
- miR-340 induced apoptosis by increasing cleaved CASP3 and BAX, and decreasing BCL2.
- miR-340 suppressed AKT phosphorylation and increased p27 levels, while p21 remained unaffected.
Conclusions:
- miR-340 exhibits tumor-suppressive properties in gastric cancer by inhibiting proliferation and inducing apoptosis.
- The AKT signaling pathway is implicated in miR-340's mechanism of action.
- miR-340 presents a promising therapeutic candidate for gastric cancer intervention.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway